About the bill
H.R. 5723 requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use data is currently tracked and monitored through Medicare claims data. MedPAC will also identify areas in which further data/methods are needed to fully understand opioid utilization patterns in Medicare. MedPAC may also issue recommendations for addressing any perverse incentives in the hospital payment systems related to prescribing opioids over non-opioid alternatives.
Sponsor and status
Sponsor. Representative for New York's 22nd congressional district. Republican.
Last Updated: Jun 20, 2018
Length: 3 pages
115th Congress (2017–2019)
This bill was introduced in a previous session of Congress and was passed by the House on June 19, 2018 but was never passed by the Senate.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
4 Cosponsors (3 Republicans, 1 Democrat)
May 9, 2018
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
May 16, 2018
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
Jun 19, 2018
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.
Jun 19, 2018
Reported by House Committee on Ways and Means
A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.
H.R. 5723 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 5723. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2023). H.R. 5723 — 115th Congress: Expanding Oversight of Opioid Prescribing and Payment Act of 2018. Retrieved from https://www.govtrack.us/congress/bills/115/hr5723
“H.R. 5723 — 115th Congress: Expanding Oversight of Opioid Prescribing and Payment Act of 2018.” www.GovTrack.us. 2018. May 28, 2023 <https://www.govtrack.us/congress/bills/115/hr5723>
Expanding Oversight of Opioid Prescribing and Payment Act of 2018, H.R. 5723, 115th Cong..
|title=H.R. 5723 (115th)
|accessdate=May 28, 2023
|author=115th Congress (2018)
|date=May 9, 2018
|quote=Expanding Oversight of Opioid Prescribing and Payment Act of 2018
- show another citation format:
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.